Chemokines and Receptors – Essential Regulators of Immune Response
258 products
258 products
Chemokines and their receptors are at the core of immune system signaling, guiding cell movement, and controlling inflammatory responses. These small proteins influence everything from immune defense to disease progression, making them essential for biomedical research and therapeutic development.
At Beta LifeScience, we offer high-quality chemokine proteins and receptors to support researchers in immunology, oncology, and drug discovery. Our products are designed for precision and reliability, ensuring consistent results for your studies.
Explore our extensive collection of chemokines and receptors to enhance your research with trusted, high-purity reagents.
Chemokine receptors are specialized proteins found on the surface of immune cells, responsible for detecting chemokine signals and guiding cell movement. These receptors play a crucial role in immune surveillance, inflammation control, and even disease progression. When chemokines bind to their specific receptors, they trigger intracellular signaling pathways that direct white blood cells to infection sites, inflamed tissues, or areas requiring immune regulation.
Chemokines are small signaling proteins that regulate immune cell movement, ensuring a precise and controlled immune response. They bind to chemokine receptors on the surface of white blood cells, guiding them to infection sites, inflammation zones, and areas needing tissue repair. Chemokines and receptors are essential for immune surveillance, inflammation control, and even tumor progression, making them key players in both health and disease.
Chemokine proteins act as molecular signals that attract white blood cells, such as T cells and macrophages, to specific locations. These proteins bind to chemokine receptors—like the CXC chemokine receptor type 1 (CXCR1) and CCR5 chemokine receptor—triggering a cascade of cellular responses. This process is crucial in defending against infections, controlling immune responses, and managing tissue repair. When chemokine function is disrupted, it can lead to immune deficiencies or excessive inflammation.
A chemokine receptor is a type of G-protein-coupled receptor (GPCR) that binds chemokine proteins to regulate immune cell movement. These receptors are essential for guiding immune responses, preventing infections, and balancing inflammation. Malfunctioning or overactive receptors can lead to autoimmune diseases, chronic inflammation, or even cancer progression.
Dysregulation of chemokines and receptors is linked to serious conditions, including autoimmune diseases, chronic inflammation, and cancer. Overactive chemokine signaling can fuel inflammatory disorders, while inadequate function can weaken immune defense. In cancer, chemokines organize the tumor microenvironment, influencing tumor growth, metastasis, and immune evasion. Understanding these pathways helps researchers develop therapies that target chemokine receptor antagonists, offering potential treatments for immune-related diseases and cancer progression.
Chemokine receptors are divided into four main families based on their structure and the type of chemokine they bind to. Each receptor type plays a distinct role in immune regulation, directing white blood cells to areas of infection, inflammation, or tissue repair.
These receptors bind to CC chemokines, which have two adjacent cysteine residues. They regulate the movement of monocytes, macrophages, T cells, and dendritic cells, playing a crucial role in inflammation and immune surveillance. Some key CCRs include:
CCR5 – Involved in viral infections like HIV and inflammatory diseases.
CCR2 – Regulates monocyte migration and contributes to chronic inflammatory conditions.
CXC receptors bind to CXC chemokines, which have a single amino acid between their first two cysteine residues. These receptors primarily regulate neutrophil recruitment and angiogenesis (blood vessel formation). Notable CXCRs include:
CXCR1 & CXCR2 – Control neutrophil migration to infection sites, reducing inflammation.
CXCR4 – Plays a role in stem cell homing and cancer metastasis.
CX3C receptors interact with CX3C chemokines, which have three amino acids between their cysteine residues. They are unique because they can function as both soluble and membrane-bound molecules, helping regulate immune cell adhesion and migration. A key example is:
CX3CR1 – Essential for monocyte survival and neuron-immune interactions.
XC receptors bind to XC chemokines, which have only one cysteine residue at each end. This small receptor family mainly influences lymphocyte migration and immune homeostasis. An example is:
XCR1 – Regulates T cell activity and immune tolerance.
Chemokines play a crucial role in shaping the tumor microenvironment (TME) by regulating immune cell infiltration, tumor growth, and metastasis. These signaling proteins control how immune cells, fibroblasts, and blood vessels interact within tumors. Some chemokines, such as CXCL12, promote tumor cell survival and angiogenesis, while others, like CCL2, recruit macrophages that support cancer progression.
When chemokine balance is disrupted, tumors can evade immune responses, creating an environment that fosters uncontrolled growth and drug resistance. This makes chemokines essential targets for improving cancer immunotherapy.
Researchers are exploring how blocking chemokine receptors can help suppress tumor growth and enhance immune system attacks on cancer cells. Inhibiting key receptors like CCR5 and CXCR4 has shown promise in slowing metastasis and improving the effectiveness of existing treatments.
Some emerging therapeutic strategies include:
CCR5 inhibitors – Used to prevent tumor cell migration and invasion.
CXCR4 antagonists – Block pathways that fuel metastasis and drug resistance.
Combination therapies – Pairing chemokine inhibitors with immunotherapy or chemotherapy to improve patient outcomes.
Chemokines are essential for immune cell communication, but imbalanced chemokine signaling can drive chronic inflammation and autoimmune diseases. In conditions like rheumatoid arthritis, lupus, and multiple sclerosis, excessive chemokine activity leads to uncontrolled immune cell migration, attacking healthy tissues instead of infections. This dysregulation fuels persistent inflammation, tissue damage, and disease progression, making chemokines a critical factor in autoimmunity.
Targeting chemokine receptors has opened new doors for treating inflammatory diseases. Chemokine receptor antagonists are being developed to block harmful immune cell migration, reducing inflammation and preventing tissue damage. These inhibitors show promise in conditions like Crohn’s disease and psoriasis, offering more precise and effective treatments compared to traditional immunosuppressants. With ongoing research, chemokine-targeted therapies could redefine autoimmune disease management and improve patient outcomes.
At Beta LifeScience, we provide high-purity chemokine proteins trusted by researchers and professionals worldwide. Our chemokines are carefully tested to ensure optimal bioactivity, stability, and consistency, making them ideal for applications in immunology, cancer research, and drug development. With strict quality control and batch-to-batch reliability, our products help scientists achieve reproducible and accurate results in their studies.
We offer a diverse selection of recombinant chemokines and receptors, including key members of the CXCL and CCL families that play essential roles in immune signaling. Whether you need CXC chemokine receptor type 1 (CXCR1) for inflammation studies or CCR5 chemokine receptor for viral infection research, our catalog includes the essential proteins required for cutting-edge experiments.
We understand that precision and performance are critical in research, which is why our chemokines undergo rigorous purification and activity validation. Every product is designed to meet industry-leading standards for purity, ensuring that you get reliable and reproducible data every time.
When it comes to sourcing high-quality chemokines and receptors, Beta LifeScience is the partner you can trust to support groundbreaking discoveries in immunology, oncology, and beyond.
Features:
Chemokine receptors are cell surface proteins that detect chemokine signals and guide immune cell movement. By binding to specific chemokines, these receptors help regulate inflammation, infection response, and tissue repair.
Chemokine receptor antagonists are drugs designed to block chemokine receptors, preventing excessive immune cell migration. These inhibitors are being explored for treating inflammatory diseases, autoimmune conditions, and even cancer.
Yes, chemokines are a specialized subset of cytokines responsible for directing immune cells to infection sites. While all chemokines are cytokines, not all cytokines function as chemokines.
Chemokines influence tumor growth by attracting immune cells to the tumor site. However, some tumors exploit chemokines to evade immune attacks, making chemokines a key target in cancer therapy research.
No, C5a is a complement protein fragment, not a chemokine. While C5a plays a role in immune cell recruitment and inflammation, it belongs to the complement system, not the chemokine family.
Cytokines are broad signaling proteins that regulate the immune response, while chemokines specifically control immune cell movement. Chemokines act as molecular "traffic signals", directing white blood cells where they are needed most.